363 related articles for article (PubMed ID: 17613889)
1. Effect of cations and anions on glass transition temperatures in excipient solutions.
Nesarikar VV; Nassar MN
Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
[TBL] [Abstract][Full Text] [Related]
2. Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.
Her LM; Deras M; Nail SL
Pharm Res; 1995 May; 12(5):768-72. PubMed ID: 7479566
[TBL] [Abstract][Full Text] [Related]
3. Measurement of glass transition temperatures in freeze concentrated solutions of non-electrolytes by electrical thermal analysis.
Her LM; Jefferis RP; Gatlin LA; Braxton B; Nail SL
Pharm Res; 1994 Jul; 11(7):1023-9. PubMed ID: 7937543
[TBL] [Abstract][Full Text] [Related]
4. Method development and analysis of the water content of the maximally freeze concentrated solution suitable for protein lyophilisation.
Seifert I; Bregolin A; Fissore D; Friess W
Eur J Pharm Biopharm; 2020 Aug; 153():36-42. PubMed ID: 32526356
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
Tang XC; Pikal MJ
Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
[TBL] [Abstract][Full Text] [Related]
6. Freeze-concentration separates proteins and polymer excipients into different amorphous phases.
Izutsu K; Kojima S
Pharm Res; 2000 Oct; 17(10):1316-22. PubMed ID: 11145240
[TBL] [Abstract][Full Text] [Related]
7. Colyophilized Sugar-Polymer Dispersions for Enhanced Processing and Storage Stability.
Giannachi C; Allen E; Egan G; Vucen S; Crean A
Mol Pharm; 2024 Jun; 21(6):3017-3026. PubMed ID: 38758116
[TBL] [Abstract][Full Text] [Related]
8. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
Hawe A; Friess W
Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
[TBL] [Abstract][Full Text] [Related]
9. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate.
Lueckel B; Bodmer D; Helk B; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553
[TBL] [Abstract][Full Text] [Related]
10. Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying.
Shalaev EY; Johnson-Elton TD; Chang L; Pikal MJ
Pharm Res; 2002 Feb; 19(2):195-201. PubMed ID: 11883647
[TBL] [Abstract][Full Text] [Related]
11. Amorphous-Amorphous Phase Separation of Freeze-Concentrated Protein and Amino Acid Excipients for Lyophilized Formulations.
Izutsu KI; Yoshida H; Shibata H; Goda Y
Chem Pharm Bull (Tokyo); 2016; 64(12):1674-1680. PubMed ID: 27904076
[TBL] [Abstract][Full Text] [Related]
12. Mechanical Characterization of Vial Strain During Freezing and Thawing Operations Using Amorphous Excipients.
Strongrich A; Flynn I; Bhatnagar B; Shalaev E; Tchessalov S
J Pharm Sci; 2024 May; ():. PubMed ID: 38825234
[TBL] [Abstract][Full Text] [Related]
13. Crystallization of mannitol below Tg' during freeze-drying in binary and ternary aqueous systems.
Pyne A; Surana R; Suryanarayanan R
Pharm Res; 2002 Jun; 19(6):901-8. PubMed ID: 12134964
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of buffering agents on the crystallization of gemcitabine hydrochloride in frozen solutions.
Patel M; Munjal B; Bansal AK
Int J Pharm; 2014 Aug; 471(1-2):56-64. PubMed ID: 24836665
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.
Hawe A; Friess W
AAPS PharmSciTech; 2006; 7(4):94. PubMed ID: 17285745
[TBL] [Abstract][Full Text] [Related]
16. Freeze-Drying From Organic Cosolvent Systems, Part 1: Thermal Analysis of Cosolvent-Based Placebo Formulations in the Frozen State.
Kunz C; Schuldt-Lieb S; Gieseler H
J Pharm Sci; 2018 Mar; 107(3):887-896. PubMed ID: 29133233
[TBL] [Abstract][Full Text] [Related]
17. Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers.
Eriksson JH; Hinrichs WL; de Jong GJ; Somsen GW; Frijlink HW
Pharm Res; 2003 Sep; 20(9):1437-43. PubMed ID: 14567639
[TBL] [Abstract][Full Text] [Related]
18. Effect of polymer size and cosolutes on phase separation of poly(vinylpyrrolidone) (PVP) and dextran in frozen solutions.
Izutsu K; Aoyagi N; Kojima S
J Pharm Sci; 2005 Apr; 94(4):709-17. PubMed ID: 15682383
[TBL] [Abstract][Full Text] [Related]
19. The effect of mAb and excipient cryoconcentration on long-term frozen storage stability - Part 1: Higher molecular weight species and subvisible particle formation.
Bluemel O; Anuschek M; Buecheler JW; Hoelzl G; Bechtold-Peters K; Friess W
Int J Pharm X; 2022 Dec; 4():100108. PubMed ID: 35024603
[TBL] [Abstract][Full Text] [Related]
20. Using dextran of different molecular weights to achieve faster freeze-drying and improved storage stability of lactate dehydrogenase.
Larsen BS; Skytte J; Svagan AJ; Meng-Lund H; Grohganz H; Löbmann K
Pharm Dev Technol; 2019 Mar; 24(3):323-328. PubMed ID: 29781745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
